References
  1. Kim JG, Sohn SK, Kim DH, et al. Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 2005;35:489–95.
  2. Dietz AC, Lucchini G, Samarasinghe S, et al. Evolving hematopoietic stem cell transplantation strategies in severe aplastic anemia. Curr Opin Pediatr. 2016;28:3-11.
  3. Konishi A, Abe M, Yamaoka M, et al. Analysis of HLA haplotype and clinical factors during hematopoietic stem cell transplantation. Transpl Immunol. 2021;66:101376.
  4. Li Y, Duan F, Xiao H, et al. Therapeutic Outcomes of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Multicenter Study. Transplantation. 2018;102:1724-31.
  5. Bodine DM, Seidel NE, Orlic D. Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow. Blood. 1996;88:89-97.
  6. Hartung HD, Olson TS, Bessler M. Acquired aplastic anemia in children. Pediatr Clin North Am. 2013;60:1311-36.
  7. Borhany M, Ali MS, Ghias Z, et al. The Impact of ABO Incompatibility on the Outcomes of Hematopoietic Stem Cell Transplantation: A Single-Center Study From Pakistan. Cureus. 2023;15:e45442.
  8. Shokrgozar N, Tamaddon G. ABO Blood Grouping Mismatch in Hematopoietic Stem Cell Transplantation and Clinical Guides. Int J Hematol Oncol Stem Cell Res. 2018;12:322-8.
  9. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15:825-8.
  10. Sullivan KM, Shulman HM, Storb R, et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood. 1981;57:267-76.
  11. Vela-Ojeda J, Tripp-Villanueva F, Sanchez-Cortés E, et al. Intravesical rhGM-CSF for the treatment of late onset hemorrhagic cystitis after bone marrow transplant. Bone Marrow Transplant. 1999;24:1307-10.
  12. Ruutu T, Barosi G, Benjamin RJ, et al. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica. 2007;92:95-100.
  13. Canals C, Muñiz-Díaz E, Martínez C, et al. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning. Transfusion. 2004;44:1603-11.
  14. Worel N, Greinix HT, Leitner G, et al. ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy. Transfus Apher Sci. 2007;36:297-304.
  15. Helming AM, Brand A, Wolterbeek R,et al. ABO incompatible stem cell transplantation in children does not influence outcome. Pediatr Blood Cancer. 2007;49:313-7.
  16. Jiménez-Ochoa MA, Contreras-Serratos MM, González-Bautista ML, et al. ABO incompatibility and complications in hematopoietic stem cell transplantation. Rev Med Inst Mex Seguro Soc. 2023;61(Suppl 1):S12-S18.
  17. Valentini CG, Metafuni E, Gallo L, et al. ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- and Long-term Outcomes. Transplant Direct. 2021;7:e724.
  18. Ma YR, Wang WJ, Cheng YF, et al. Impact of ABO incompatibility on outcomes after haploidentical hematopoietic stem cell transplantation for severe aplastic anemia. Bone Marrow Transplant. 2020;55:1068-75.
  19. Ravn V, Dabelsteen E. Tissue distribution of histo-blood group antigens. APMIS. 2000;108:1-28.
  20. Gutiérrez-Aguirre CH, Gómez-De-León A, Alatorre-Ricardo J, et al. Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different? Transfusion. 2014;54:1269-77.
  21. Sever T, Kirkiz S, Kaya Z, et al. Impact of peri-transplant RBC transfusion and ABO incompatibility on acute graft-versus-host disease in pediatric hematopoietic stem cell transplant patients. Transfus Apher Sci. 2022;61:103352.
  22. Reed M, Yearsley M, Krugh D, et al. Severe hemolysis due to passenger lymphocyte syndrome after hematopoietic stem cell transplantation from an HLA-matched related donor. Arch Pathol Lab Med. 2003;127:1366-68.
  23. Aung FM, Lichtiger B, Bassett R, et al. Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation. Br J Haematol. 2013;160:798-805.
  24. Zhu P, Wu Y, Cui D, et al. Prevalence of Pure Red Cell Aplasia Following Major ABO-Incompatible Hematopoietic Stem Cell Transplantation. Front Immunol. 2022;13:829670.